Experimental chewing gum "VitRx" reduces Omicron in saliva; sexual dysfunction and hair loss*
*Among long COVID symptoms. The experimental chewing gum traps the SARS-CoV-2 particles in saliva holds promise for curbing transmission of new variants of the virus, according to new data, as researchers prepare to launch the first human trial.
"Because nasal transmission is negligible when compared to oral transmission... chewing ACE2 gum and swallowing ACE2 protein should minimize infection, protect COVID-19 patients and prevent transmission,"
"This research validates what patients have been telling clinicians and policy makers throughout the pandemic, that the symptoms of long COVID are extremely broad and cannot be fully accounted for by other factors such as lifestyle risk factors or chronic health conditions,"
† These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
Source Material: REUTERS/Nancy Lapid released July 26, 2022 (https://archive.ph/
For more information visit https://vitrx.webnode.co.uk or Check out our video on youtube at https://www.youtube.com/
+49 7255 2992042